ARCHIVES

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

L.A. County Nears Crucial Decision On Construction Funds

January 7, 1977

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

Congress Approves FY 1980 HEW Funds

November 23, 1979

NCI Supports Development Of Reinoids for Prevention; No Magic Bullet

May 6, 1977